Bavarian Nordic
Bavarian Nordic A/S, a leading biotechnology company headquartered in Denmark (DK), is renowned for its innovative approach in the field of immunotherapy and vaccine development. Founded in 1994, the company has made significant strides in combating infectious diseases and cancer, with a strong operational presence across Europe and North America. Specialising in the development of live virus vaccines and immunotherapies, Bavarian Nordic's core products include the smallpox vaccine, IMVAMUNE®, and the cancer immunotherapy candidate, BN-Brachyury. These offerings are distinguished by their unique mechanisms and robust safety profiles, positioning the company as a key player in the biopharmaceutical industry. With a commitment to advancing public health, Bavarian Nordic has achieved notable milestones, including partnerships with global health organisations, solidifying its reputation as a trusted innovator in vaccine technology.
DitchCarbon Score
How does Bavarian Nordic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bavarian Nordic's score of 44 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bavarian Nordic's reported carbon emissions
In 2023, Bavarian Nordic reported total carbon emissions of approximately 10,682,000 kg CO2e. This figure includes 4,364,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 6,318,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity and heat. The company has set a long-term commitment to achieve Net Zero emissions by 2050, in alignment with the Paris Agreement on Climate Change. In 2024, Bavarian Nordic plans to define its reduction pathway to meet this target. Additionally, the company is focused on reducing its carbon footprint in the near term, with specific actions planned for 2024. Bavarian Nordic's emissions data is self-reported and does not include Scope 3 emissions, which cover indirect emissions in the value chain. The company has not inherited emissions data from any parent organization, ensuring that its reported figures are solely its own. Overall, Bavarian Nordic is actively working towards significant climate commitments, aiming for substantial reductions in its carbon emissions as part of its sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 992,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,686,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bavarian Nordic is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
